Inorganic Chemistry
Article
Synthesis of [Ir(ppy)2(μ-PDI)]4(PF6)4 (Ir1). Prepared by the
general procedure above using [Ir(ppy)2(NCMe)2]PF6 (63 mg) and
PDI (12 mg). Yield: 39 mg, 58%. 1H NMR (600 MHz, CD3CN): δ =
9.16 (s, 8H, ppy, Ar H), 8.13 (s, 16H, ppy, Ar H), 7.75 (s, 8H, ppy, Ar
H), 7.59−7.32 (m, 24H, ppy/PDI, Ar H), 7.01 (s, 8H, ppy, Ar H),
6.88 (s, 8H, ppy, Ar H), 6.11 (s, 8H, ppy, Ar H). HRMS (ESI) m/z:
[M − 2PF6]2+ calcd, 1403.22708; found, 1403.26009; [M − 3PF6]3+
(q, J = 9.0, 8.2 Hz, 8H, bt, Ar H), 7.76 (t, J = 7.6 Hz, 8H, bt, Ar H),
7.71−7.62 (m, 8H, bt, Ar H), 7.59−7.49 (m, 16H, EDI, Ar H), 7.45−
7.26 (m, 16H, EDI, Ar H), 7.08 (dd, J = 9.9, 5.6 Hz, 8H, bt, Ar H),
6.92 (q, J = 7.4 Hz, 8H, bt, Ar H), 6.24 (d, J = 7.4 Hz, 8H, bt, Ar H).
HRMS (ESI) m/z: [M − 3PF6]3+ calcd, 1169.79707; found,
1169.85281. FT-IR (cm−1): 2139 (νCN
), 2168 (sh) (νCN).
̃ ̃
Synthesis of [Ir4(piq)8(μ-EDI)4](PF6)4 (Ir9). Prepared by the
general procedure using [Ir(piq)2(NCMe)2]PF6 (29 mg) and EDI (8
mg). Yield: 22 mg, 63%. 1H NMR (500 MHz, CD3CN): δ = 9.14 (t, J
= 6.0 Hz, 8H, piq, Ar H), 8.97 (d, J = 8.7 Hz, 8H, piq, Ar H), 8.33 (d,
J = 7.7 Hz, 8H, piq, Ar H), 8.18 (t, J = 6.4 Hz, 8H, piq, Ar H), 8.01−
7.77 (m, 24H, piq, Ar H), 7.62−7.30 (m, 32H, EDI, Ar H), 7.11 (t, J
= 6.6 Hz, 8H, piq, Ar H), 6.86 (t, J = 7.7 Hz, 8H, piq, Ar H), 6.19 (q,
J = 6.9 Hz, 8H, piq, Ar H). HRMS (ESI) m/z: [M − 3PF6]3+ calcd,
calcd, 887.16314; found, 887.17682. FT-IR (cm−1): 2131 (νCN
̃
), 2167
(sh) (νCN).
̃
Synthesis of [Ir(bt)2(μ-PDI)]4(PF6)4 (Ir2). Prepared by the
general procedure using [Ir(bt)2(NCMe)2]PF6 (59 mg) and PDI (9
1
mg). Yield: 33 mg, 53%. H NMR (600 MHz, CD3CN): δ = 8.39−
8.13 (m, 16H, bt, Ar H), 7.90−7.56 (m, 24H, bt, Ar H), 7.52−7.24
(m, 16H, PDI, Ar H), 7.04 (s, 8H, bt, Ar H), 6.89 (s, 8H, bt, Ar H),
6.17 (s, 8H, bt, Ar H). HRMS (ESI) m/z: [M − 2PF6]2+ calcd,
1627.11536; found, 1627.16055; [M − 3PF6]3+ calcd, 1036.42110;
1153.91328; found, 1153.96859. FT-IR (cm−1): 2132 (νCN
̃
), 2155
(sh) (νCN).
̃
found, 1036.44181. FT-IR (cm−1): 2126 (νCN
), 2171 (sh) (νCN).
̃ ̃
General Procedure for Synthesis of Diisocyanide Ligands.
The linear BLs were synthesized via a known two-step procedure for
converting aniline precursors into isocyanides.47 The dianiline
precursor is formylated using acetic formic anhydride, prepared in
situ through reaction of acetic anhydride and formic acid. Formic acid
(32 equiv) and acetic anhydride (33 equiv) are allowed to stir
together at 0 °C for 30 min. Afterward, the mixture is allowed to
reflux at 60 °C for 3 h. After cooling to room temperature the
prepared acetic formic anhydride is added to the aniline precursor
(1.0 equiv) dissolved in tetrahydrofuran and allowed to stir overnight.
The solvent was then removed under vacuum, yielding a white or tan
solid. The solid was collected in a vial and dried under vacuum with
gentle heating at 30 °C for 24 h. The resulting formylamide is then
dehydrated with phosphoryl chloride and diisopropyl amine to yield
the linear diisocyanides. Without further purification, the formylamide
(1.0 equiv) from the first step was added to dichloromethane forming
a suspension. Diisopropylamine (7.0 equiv) and phosphorous
oxychloride (2.8 equiv) were added to the suspension. The mixture
was cooled to 0 °C and allowed to stir for 30 min, followed by 8 h of
stirring at room temperature. The reaction was quenched by adding
saturated aqueous Na2CO3 and stirred for 24 h. A biphasic extraction
with dichloromethane was performed with two brine washes. The
organic layer was dried over MgSO4, then filtered, and the solvent was
removed under vacuum yielding the crude product. The product was
purified by performing a silica flash column eluted with dichloro-
methane, yielding the pure diisocyanide.
Synthesis of [Ir(piq)2(μ-PDI)]4(PF6)4 (Ir3). Prepared by the
general procedure using [Ir(piq)2(NCMe)2]PF6 (37 mg) and PDI (6
mg). Yield: 20 mg, 51%. 1H NMR (500 MHz, CD3CN): δ = 9.04 (s,
8H, piq, Ar H), 8.92 (s, 8H, piq, Ar H), 8.28 (s, 8H, piq, Ar H), 8.14
(s, 8H, piq, Ar H), 8.00−7.71 (m, 24H, piq, Ar H), 7.64−7.24 (m,
24H, piq/PDI, Ar H), 7.07 (s, 8H, piq, Ar H), 6.83 (s, 8H, piq, Ar H),
6.11 (s, 8H, piq, Ar H). HRMS (ESI) m/z: [M − 2PF6]2+ calcd,
1603.28968; found, 1603.30502; [M − 3PF6]3+ calcd, 1020.53821;
found, 1020.55971. FT-IR (cm−1): 2127 (νCN
), 2170 (sh) (νCN).
̃ ̃
Synthesis of [Ir(ppy)2(μ-BPDI)]4(PF6)4 (Ir4). Prepared by the
general procedure using [Ir(ppy)2(NCMe)2]PF6 (30 mg) and BPDI
1
(8 mg). Yield: 16 mg, 46%. H NMR (500 MHz, CD3CN): δ = 9.26
(s, 8H, ppy, Ar H), 8.14 (d, J = 24.8 Hz, 16H, ppy, Ar H), 7.79 (s, 8H,
ppy, Ar H), 7.73−7.63 (m, 16H, BPDI, Ar H), 7.61−7.38 (m, 24H,
ppy/BPDI, Ar H), 7.02 (d, J = 7.3 Hz, 8H, ppy, Ar H), 6.92 (s, 8H,
ppy, Ar H), 6.19 (d, J = 7.7 Hz, 8H, ppy, Ar H). HRMS (ESI) m/z:
[M − 2PF6]2+ calcd, 1555.28968; found, 1555.32318; [M − 3PF6]3+
calcd, 988.53821; found, 988.55519. FT-IR (cm−1): 2131 (νCN
̃
), 2162
(sh) (νCN).
̃
Synthesis of [Ir(bt)2(μ-BPDI)]4(PF6)4 (Ir5). Prepared by the
general procedure using [Ir(bt)2(NCMe)2]PF6 (30 mg) and BPDI (8
mg). Yield: 14 mg, 40%. 1H NMR (500 MHz, CD3CN): δ = 8.42 (d, J
= 8.2 Hz, 8H, bt, Ar H), 8.23 (s, 8H, bt, Ar H), 7.86 (d, J = 8.6 Hz,
8H, bt, Ar H), 7.75 (s, 8H, bt, Ar H), 7.70−7.52 (m, 24H, bt/BPDI,
Ar H), 7.41−7.30 (m, 16H, BPDI, Ar H), 7.07 (t, J = 7.1 Hz, 8H, bt,
Ar H), 6.93 (t, J = 7.7 Hz, 8H, bt, Ar H), 6.25 (d, J = 7.6 Hz, 8H, bt,
Ar H). HRMS (ESI) m/z: [M − 2PF6]2+ calcd, 1779.17796; found,
1779.20868; [M − 3PF6]3+ calcd, 1137.79707; found, 1137.81026.
Synthesis of BPDI. Prepared by general procedure using
benzidine (513 mg, 28 mmol, 1.0 equiv) with acetic anhydride (9
mL, 92 mmol, 33 equiv) and formic acid (3.5 mL, 90 mmol, 32
equiv). Yield: 524 mg, 78%. N,N′-[1,1′-biphenyl]-4,4′-diyl-bis-
(formamide) (227 mg, 0.94 mmol, 1.0 equiv) with diisopropylamine
(0.5 mL, 62 mmol, 6.0 equiv) and phosphorous oxychloride (0.4 mL,
38 mmol, 4.0 equiv). Yield: 82 mg, 38%. 1H NMR (600 MHz,
CD2Cl2): δ = 7.59 (d, J = 8.3 Hz, 4H), 7.46 (d, J = 8.2 Hz, 4H).
13C{1H} NMR (151 MHz, CD2Cl2): δ (ppm) 165.7, 140.5, 128.2,
FT-IR (cm−1): 2144 (νCN
), 2170 (sh) (νCN).
̃ ̃
Synthesis of [Ir(piq)2(μ-BPDI)]4(PF6)4 (Ir6). Prepared by the
general procedure using [Ir(piq)2(NCMe)2]PF6 (24 mg) and BPDI
1
(6 mg). Yield: 21 mg, 78%. H NMR (500 MHz, CD3CN): δ = 9.16
(s, 8H, piq, Ar H), 8.97 (d, J = 7.3 Hz, 8H, piq, Ar H), 8.32 (d, J = 9.5
Hz, 8H, piq, Ar H), 8.22−8.09 (m, 8H, piq, Ar H), 8.00−7.76 (m,
24H, piq, Ar H), 7.72−7.53 (m, 16H, BPDI, Ar H), 7.53−7.32 (m,
16H, BPDI, Ar H), 7.10 (d, J = 9.0 Hz, 8H, piq, Ar H), 6.86 (s, 8H,
piq, Ar H), 6.19 (d, J = 7.6 Hz, 8H, piq, Ar H). HRMS (ESI) m/z: [M
− 2PF6]2+ calcd, 1755.35228; found, 1755.36982; [M − 3PF6]3+
127.1, 126.4. FT-IR (cm−1): 2124 (νCN
̃
).
Synthesis of EDI. Prepared by general procedure of diisocyanide
ligands using 4,4′-ethyne-1,2-diyldianiline (500 mg, 2.4 mmol, 1.0
equiv) with acetic anhydride (8 mL, 79 mmol, 33 equiv) and formic
acid (3 mL, 76 mmol, 32 equiv). Yield: 568 mg, 89%. 4,4′-Ethyne-1,2-
diyl-bis(formamide) (268 mg, 1.0 mmol, 1.0 equiv) with diisopropyl-
amine (0.5 mL, 71 mmol, 7.0 equiv) and phosphorous oxychloride
calcd, 1121.91328; found, 1121.92311. FT-IR (cm−1): 2140 (νCN
̃
),
2166 (sh) (νCN).
̃
Synthesis of [Ir(ppy)2(μ-EDI)]4(PF6)4 (Ir7). Prepared by the
general procedure using [Ir(ppy)2(NCMe)2]PF6 (28 mg) and EDI (8
mg). Yield: 27 mg, 83%. 1H NMR (500 MHz, CD3CN): δ = 9.24 (s,
8H ppy, Ar H), 8.19−8.09 (m, 16H ppy, Ar H), 7.79 (d, J = 8.0 Hz,
8H ppy, Ar H), 7.64−7.53 (m, 16H EDI, Ar H), 7.47−7.35 (m, 24H
ppy/EDI, Ar H), 7.03 (t, J = 7.7 Hz, 8H ppy, Ar H), 6.92 (t, J = 7.4
Hz, 8H ppy, Ar H), 6.18 (d, J = 8.0 Hz, 8H ppy, Ar H). HRMS (ESI)
m/z: [M − 3PF6]3+ calcd, 1020.53821; found, 1020.58226. FT-IR
1
(0.3 mL, 28 mmol, 2.8 equiv). Yield: 85 mg, 36%. H NMR (600
MHz, CD2Cl2): δ = 7.55 (d, J = 8.3 Hz, 4H), 7.37 (d, J = 8.2 Hz, 4H).
13C{1H} NMR (151 MHz, CD2Cl2): δ (ppm) 166.5, 132.7, 126.7,
126.2, 123.9, 90.2. FT-IR (cm−1): 2125 (νCN
̃
).
(cm−1): 2136 (νCN
), 2165 (sh) (νCN).
̃ ̃
ASSOCIATED CONTENT
■
Synthesis of [Ir(bt)2(μ-EDI)]4(PF6)4 (Ir8). Prepared by the
general procedure using [Ir(bt)2(NCMe)2]PF6 (24 mg) and EDI (6
mg). Yield: 14 mg, 48%. 1H NMR (500 MHz, CD3CN): δ = 8.39 (d, J
= 8.7 Hz, 8H, bt, Ar H), 8.23 (q, J = 7.9, 6.0 Hz, 8H, bt, Ar H), 7.86
sı
* Supporting Information
The Supporting Information is available free of charge at
5905
Inorg. Chem. 2021, 60, 5898−5907